MicroRNA-26a systemic administration attenuates tumor formation in hepatocellular carcinoma mouse model

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Badr A.M.; El-Ahwany E.; Goda L.; Nagy F.; Helal N.; Deeb S.E.

Journal: Pakistan Journal of Pharmaceutical Sciences

Publisher: Pakistan Journal of Pharmaceutical Sciences

Publication Date: 1 May 2021

Volume / Issue: Volume 34 / Issue 3

Pages: 925–932

ISSN: 1011601X

DOI: 10.36721/PJPS.2021.34.3.REG.925-932.1

Scopus: View on Scopus

PubMed: 34602415

Document Type: Article

Access: All Open Access; Gold Open Access


Authors and Affiliations

Badr A.M., Zoology Department, Faculty of Science, Cairo University, Giza, Egypt; El-Ahwany E., Immunology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Goda L., Zoology Department, Faculty of Science, Cairo University, Giza, Egypt; Nagy F., Immunology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Helal N., Pathology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Deeb S.E., Zoology Department, Faculty of Science, Cairo University, Giza, Egypt


Abstract

MicroRNA (miRNA)-26a is one of the tumor suppressor genes that has been down regulated during the development of hepatocellular carcinoma (HCC). This work was conducted to evaluate the possible preventive effect of exogenous miRNA-26a administration on diethylnitrosamine (DEN)-mediated HCC. Balb/C mice were intraperitoneally injected with saline (Normal group), DEN (HCC group) or miRNA-26a (HCC+miRNA-26a group). On week 8, 12, 16 and 20, the concentrations of alpha-fetoprotein (AFP), des-gamma carboxyprothrombin (DCP), the levels of helper T cells-associated cytokines, and the vascular endothelial growth factor (VEGF), were measured. Flow cytometry determined the frequencies of regulatory T (Treg) cells. The concentrations of AFP, DCP and VEGF, as well as the frequency of Treg cells showed significantly lower values following miRNA-26a administration than in HCC group. miRNA-26a administration has reduced the levels of IL (interleukin)-2 and TNF (tumor necrosis factor)-α, in contrast, IL-10 level was markedly elevated in comparison to HCC model at all experimental time points. The restore of miRNA-26a function significantly (P<0.001) down regulated the expression levels of survivin & caspase-3 compared to HCC group. The obtained data introduce an evidence for the suppressive impact of miRNA-26a on liver tumor formation and its possible manipulation as a therapeutic design for HCC. © 2021 Pakistan Journal of Pharmaceutical Sciences. All rights reserved.


Keywords

Caspase-3; Cytokines; DEN; HCC; MiRNA-26a; Regulatory T cells; Survivin; Tumor markers; VEGF; Alkylating Agents; alpha-Fetoproteins; Animals; Apoptosis; Biomarkers; Carcinoma, Hepatocellular; Caspase 3; Diethylnitrosamine; Interleukin-10; Interleukin-2; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; MicroRNAs; Protein Precursors; Prothrombin; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes, Helper-Inducer; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; alpha fetoprotein; baculoviral IAP repeat containing protein 5; decarboxyprothrombin; interleukin 10; interleukin 2; microRNA 26a; tumor necrosis factor; vasculotropin; alkylating agent; biological marker; Casp3 protein, mouse; cytokine; IL10 protein, mouse; microRNA; Mirn26 microRNA, mouse; protein precursor; Tnf protein, mouse; vasculotropin A; animal cell; animal experiment; animal model; Article; Bagg albino mouse; controlled study; down regulation; enzyme linked immunosorbent assay; flow cytometry; histology; liver carcinogenesis; liver cell carcinoma; male; mouse; mouse model; nonhuman; protein blood level; protein expression level; regulatory T lymphocyte; animal; drug effect; experimental liver neoplasm; genetics; helper cell; liver tumor; metabolism; pathology; reverse transcription polymerase chain reaction


Citation Information

Scopus Citations: 3


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]